Reports and Findings

The AIM-BRAIN Project: Access to Innovative Molecular diagnostic profiling for paediatric brain tumours

Nick Gottardo MBChB FRACP PhD Co-Head, Brain Tumour Research team; Head of Oncology and Haematology, Perth Children’s Hospital nicholas.gottardo@thekids.org.au Head of Paediatric and Adolescent Oncology and Haematology, Perth Children’s Hospital;

SJ-ELiOT: St Jude - Phase 1 Evaluation of LY2606368, Molecularly-Targeted CHK1/2i Therapy, in Combination with Cyclophosphamide or Gemcitabine for Children and Adolescents with Refractory or Recurrent Medulloblastoma Brain Tumours

Nick Raelene Gottardo Endersby MBChB FRACP PhD BSc (Hons) PhD Co-Head, Brain Tumour Research team; Head of Oncology and Haematology, Perth Children’s Hospital Brainchild Fellow; Co-Head, Brain Tumour Research team nicholas.gottardo@thekids.org.au

Sensitising glioblastoma to enhance cancer therapy

Raelene Nick Endersby Gottardo BSc (Hons) PhD MBChB FRACP PhD Brainchild Fellow; Co-Head, Brain Tumour Research team Co-Head, Brain Tumour Research team; Head of Oncology and Haematology, Perth Children’s Hospital raelene.endersby@thekids.org.au

Radiosensitisation of medulloblastoma

Raelene Nick Endersby Gottardo BSc (Hons) PhD MBChB FRACP PhD Brainchild Fellow; Co-Head, Brain Tumour Research team Co-Head, Brain Tumour Research team; Head of Oncology and Haematology, Perth Children’s Hospital raelene.endersby@thekids.org.au

Exploring the immune microenvironment and investigating novel immunotherapeutics for medulloblastoma and paediatric high-grade glioma

Raelene Nick Endersby Gottardo BSc (Hons) PhD MBChB FRACP PhD Brainchild Fellow; Co-Head, Brain Tumour Research team Co-Head, Brain Tumour Research team; Head of Oncology and Haematology, Perth Children’s Hospital raelene.endersby@thekids.org.au

Chemosensitisation of medulloblastoma and pineoblastoma

Raelene Nick Endersby Gottardo BSc (Hons) PhD MBChB FRACP PhD Brainchild Fellow; Co-Head, Brain Tumour Research team Co-Head, Brain Tumour Research team; Head of Oncology and Haematology, Perth Children’s Hospital raelene.endersby@thekids.org.au

An initial health economic evaluation of the potential benefits gained by reducing late effects in paediatric brain cancer survivors

Raelene Nick Endersby Gottardo BSc (Hons) PhD MBChB FRACP PhD Brainchild Fellow; Co-Head, Brain Tumour Research team Co-Head, Brain Tumour Research team; Head of Oncology and Haematology, Perth Children’s Hospital raelene.endersby@thekids.org.au

CONNECT – Collaborative Network for Neuro-oncology Clinical Trials

Raelene Endersby BSc (Hons) PhD Brainchild Fellow; Co-Head, Brain Tumour Research team raelene.endersby@thekids.org.au Co-Head, Brain Tumour Research Raelene was awarded her PhD in 2003 from the Harry Perkins Institute for Medical Research (under

The Kids Cancer Biobank, patient-derived xenograft model development and genome-wide characterization

Raelene Nick Endersby Gottardo BSc (Hons) PhD MBChB FRACP PhD Brainchild Fellow; Co-Head, Brain Tumour Research team Co-Head, Brain Tumour Research team; Head of Oncology and Haematology, Perth Children’s Hospital raelene.endersby@thekids.org.au

Whole-cell pertussis vaccine in early infancy for the prevention of allergy

This is a protocol for a Cochrane Review (intervention). The objectives were to assess the efficacy and safety of whole‐cell pertussis (wP) vaccinations in comparison to acellular pertussis (aP) vaccinations in early infancy for the prevention of atopic diseases in children.